Form 4: BioLife Solutions Executive Sells Shares Under 10b5-1 Trading Plan

Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions, sold 3,000 shares of common stock on July 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On July 1, 2024, Sarah Aebersold, the Chief Human Resources Officer of BioLife Solutions Inc. (BLFS), sold 3,000 shares of the company's common stock.
• The sale was executed under a Rule 10b5-1(c) trading plan adopted on December 15, 2023.
• The shares were sold at a weighted average price of $21.03, with individual prices ranging from $20.72 to $21.40.
• Following the transaction, Aebersold directly owns 61,683 shares of BioLife Solutions.
• The reporting person has undertaken to provide full information regarding the number of shares sold at each separate price within the range upon request.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine transaction under a pre-existing trading plan. There is no indication of positive or negative implications for the company.

Positives

• The sale was executed under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.

Industry Context

Insider sales are a common occurrence in publicly traded companies. The use of a 10b5-1 trading plan suggests that the sale was pre-planned and not based on any material non-public information.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates